Iradimed Historical Financial Ratios

IRMD Stock

USD 52.96 0.10 0.19%

Iradimed is lately reporting on over 106 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 10.18 or Days Sales Outstanding of 46.78 will help investors to properly organize and evaluate Iradimed financial condition quickly.

Quick Ratio Current Ratio

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iradimed Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

About Iradimed Financial Ratios Analysis

IradimedFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Iradimed investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Iradimed financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Iradimed history.

Iradimed Financial Ratios Chart

At present, Iradimed's PTB Ratio is projected to decrease significantly based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 7.19, whereas ROIC is forecasted to decline to 0.19.

Price To Sales Ratio Dividend Yield Ptb Ratio Days Sales Outstanding Pb Ratio

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Iradimed stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Iradimed sales, a figure that is much harder to manipulate than other Iradimed Co multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Dividend Yield

Dividend Yield is Iradimed Co dividend as a percentage of Iradimed stock price. Iradimed dividend yield is a measure of Iradimed stock productivity, which can be interpreted as interest rate earned on an Iradimed investment. A financial ratio that shows how much a company pays out in dividends each year relative to its stock price, calculated as annual dividends per share divided by price per share.

Ptb Ratio

Price-to-Book ratio, a financial valuation metric used to compare a company's current market price to its book value. It provides insight into the value that market participants place on the company's equity relative to its net asset value.

Most ratios from Iradimed's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Iradimed current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Iradimed Co. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.

	2023	2024	2025 (projected)
Dividend Yield	0.0221	0.0196	0.0283
Price To Sales Ratio	9.13	9.51	9.68

Dividend Yield Price To Sales Ratio

Iradimed fundamentals Correlations

	Price To Sales Ratio	Dividend Yield	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Payout Ratio	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding
Price To Sales Ratio		0.0	0.75	0.21	-0.3	-0.65	-0.19	-0.24	-0.21	0.75	0.99	-0.21	0.33	-0.06	-0.21	0.03	0.02	-0.2	-0.16	-0.35	0.76	-0.02	0.01	-0.21	0.53	0.1
Dividend Yield	0.0		0.16	0.09	-0.56	0.1	-0.74	-0.85	-0.86	0.16	0.01	-0.54	-0.1	0.33	-0.76	-0.35	-0.12	-0.59	-0.91	-0.31	0.25	0.55	0.99	-0.79	-0.24	0.25
Ptb Ratio	0.75	0.16		0.49	-0.72	-0.45	-0.45	-0.4	-0.2	1.0	0.82	-0.5	0.64	-0.29	-0.44	0.23	-0.51	-0.59	-0.22	-0.8	0.8	0.09	0.16	-0.21	0.54	0.6
Days Sales Outstanding	0.21	0.09	0.49		-0.27	-0.38	-0.34	-0.04	-0.19	0.49	0.25	-0.41	0.29	-0.12	-0.16	0.17	-0.28	-0.16	-0.12	-0.21	0.39	0.28	0.07	0.04	0.39	0.25
Book Value Per Share	-0.3	-0.56	-0.72	-0.27		0.21	0.84	0.78	0.52	-0.72	-0.4	0.83	-0.46	0.29	0.83	-0.27	0.58	0.97	0.59	0.88	-0.61	-0.53	-0.53	0.43	-0.3	-0.68
Free Cash Flow Yield	-0.65	0.1	-0.45	-0.38	0.21		0.32	0.07	0.16	-0.45	-0.64	0.45	-0.05	0.18	0.25	-0.21	-0.08	0.18	0.01	0.23	-0.79	-0.09	0.1	-0.18	-0.81	0.06
Operating Cash Flow Per Share	-0.19	-0.74	-0.45	-0.34	0.84	0.32		0.84	0.76	-0.45	-0.24	0.96	-0.08	0.16	0.93	-0.19	0.23	0.85	0.76	0.54	-0.55	-0.82	-0.69	0.47	-0.29	-0.35
Average Payables	-0.24	-0.85	-0.4	-0.04	0.78	0.07	0.84		0.86	-0.4	-0.27	0.67	-0.06	-0.13	0.89	0.16	0.12	0.77	0.91	0.5	-0.42	-0.64	-0.8	0.8	0.08	-0.29
Capex To Depreciation	-0.21	-0.86	-0.2	-0.19	0.52	0.16	0.76	0.86		-0.2	-0.19	0.56	0.17	-0.34	0.78	0.32	-0.17	0.51	0.97	0.18	-0.34	-0.67	-0.82	0.84	0.14	0.05
Pb Ratio	0.75	0.16	1.0	0.49	-0.72	-0.45	-0.45	-0.4	-0.2		0.82	-0.5	0.64	-0.29	-0.44	0.23	-0.51	-0.59	-0.22	-0.8	0.8	0.09	0.16	-0.21	0.54	0.6
Ev To Sales	0.99	0.01	0.82	0.25	-0.4	-0.64	-0.24	-0.27	-0.19	0.82		-0.26	0.42	-0.12	-0.25	0.09	-0.1	-0.3	-0.16	-0.46	0.79	-0.01	0.01	-0.2	0.56	0.21
Free Cash Flow Per Share	-0.21	-0.54	-0.5	-0.41	0.83	0.45	0.96	0.67	0.56	-0.5	-0.26		-0.13	0.37	0.86	-0.41	0.29	0.83	0.54	0.59	-0.62	-0.75	-0.5	0.2	-0.51	-0.39
Roic	0.33	-0.1	0.64	0.29	-0.46	-0.05	-0.08	-0.06	0.17	0.64	0.42	-0.13		0.01	0.05	-0.03	-0.61	-0.36	0.03	-0.6	0.37	-0.05	-0.1	-0.03	0.3	0.59
Inventory Turnover	-0.06	0.33	-0.29	-0.12	0.29	0.18	0.16	-0.13	-0.34	-0.29	-0.12	0.37	0.01		0.17	-0.98	0.27	0.32	-0.4	0.36	-0.17	-0.07	0.35	-0.54	-0.47	-0.27
Net Income Per Share	-0.21	-0.76	-0.44	-0.16	0.83	0.25	0.93	0.89	0.78	-0.44	-0.25	0.86	0.05	0.17		-0.15	0.15	0.82	0.77	0.58	-0.55	-0.65	-0.72	0.56	-0.16	-0.3
Days Of Inventory On Hand	0.03	-0.35	0.23	0.17	-0.27	-0.21	-0.19	0.16	0.32	0.23	0.09	-0.41	-0.03	-0.98	-0.15		-0.23	-0.3	0.39	-0.28	0.14	0.18	-0.37	0.58	0.52	0.22
Payables Turnover	0.02	-0.12	-0.51	-0.28	0.58	-0.08	0.23	0.12	-0.17	-0.51	-0.1	0.29	-0.61	0.27	0.15	-0.23		0.57	-0.02	0.74	-0.2	0.05	-0.14	-0.05	-0.14	-0.96
Average Inventory	-0.2	-0.59	-0.59	-0.16	0.97	0.18	0.85	0.77	0.51	-0.59	-0.3	0.83	-0.36	0.32	0.82	-0.3	0.57		0.59	0.82	-0.52	-0.57	-0.56	0.4	-0.24	-0.67
Capex To Revenue	-0.16	-0.91	-0.22	-0.12	0.59	0.01	0.76	0.91	0.97	-0.22	-0.16	0.54	0.03	-0.4	0.77	0.39	-0.02	0.59		0.26	-0.27	-0.67	-0.87	0.91	0.25	-0.11
Cash Per Share	-0.35	-0.31	-0.8	-0.21	0.88	0.23	0.54	0.5	0.18	-0.8	-0.46	0.59	-0.6	0.36	0.58	-0.28	0.74	0.82	0.26		-0.66	-0.08	-0.32	0.2	-0.39	-0.78
Pocfratio	0.76	0.25	0.8	0.39	-0.61	-0.79	-0.55	-0.42	-0.34	0.8	0.79	-0.62	0.37	-0.17	-0.55	0.14	-0.2	-0.52	-0.27	-0.66		0.13	0.26	-0.14	0.76	0.29
Interest Coverage	-0.02	0.55	0.09	0.28	-0.53	-0.09	-0.82	-0.64	-0.67	0.09	-0.01	-0.75	-0.05	-0.07	-0.65	0.18	0.05	-0.57	-0.67	-0.08	0.13		0.48	-0.38	0.07	0.06
Payout Ratio	0.01	0.99	0.16	0.07	-0.53	0.1	-0.69	-0.8	-0.82	0.16	0.01	-0.5	-0.1	0.35	-0.72	-0.37	-0.14	-0.56	-0.87	-0.32	0.26	0.48		-0.76	-0.22	0.26
Capex To Operating Cash Flow	-0.21	-0.79	-0.21	0.04	0.43	-0.18	0.47	0.8	0.84	-0.21	-0.2	0.2	-0.03	-0.54	0.56	0.58	-0.05	0.4	0.91	0.2	-0.14	-0.38	-0.76		0.48	-0.08
Pfcf Ratio	0.53	-0.24	0.54	0.39	-0.3	-0.81	-0.29	0.08	0.14	0.54	0.56	-0.51	0.3	-0.47	-0.16	0.52	-0.14	-0.24	0.25	-0.39	0.76	0.07	-0.22	0.48		0.14
Days Payables Outstanding	0.1	0.25	0.6	0.25	-0.68	0.06	-0.35	-0.29	0.05	0.6	0.21	-0.39	0.59	-0.27	-0.3	0.22	-0.96	-0.67	-0.11	-0.78	0.29	0.06	0.26	-0.08	0.14

Click cells to compare fundamentals

Iradimed Account Relationship Matchups

Iradimed fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	8.72	13.64	6.67	9.13	9.51	9.68
Ptb Ratio	4.5	7.9	4.82	8.38	8.03	10.18
Days Sales Outstanding	52.65	44.84	90.9	68.06	52.61	46.78
Book Value Per Share	5.06	5.85	5.86	5.67	6.85	7.19
Free Cash Flow Yield	0.0187	0.0184	0.023	0.009123	0.0253	0.0257
Stock Based Compensation To Revenue	0.12	0.0349	0.0262	0.0334	0.0345	0.0402
Capex To Depreciation	0.48	0.53	2.8	10.46	9.79	10.28
Pb Ratio	4.5	7.9	4.82	8.38	8.03	10.18
Ev To Sales	5.8	7.22	12.22	5.62	8.4	8.8
Free Cash Flow Per Share	0.86	0.43	0.85	0.65	1.39	1.46
Roic	0.14	0.15	0.0253	0.12	0.16	0.19
Inventory Turnover	2.07	2.27	2.24	1.2	1.62	2.05
Net Income Per Share	0.11	0.76	1.02	1.36	1.52	1.59
Days Of Inventory On Hand	176.34	160.73	163.03	303.8	224.76	164.78
Payables Turnover	12.39	12.47	6.68	8.29	8.91	6.4
Research And Ddevelopement To Revenue	0.06	0.0456	0.0427	0.0436	0.0387	0.0619
Capex To Revenue	0.0126	0.0201	0.0177	0.0352	0.12	0.11
Cash Per Share	4.29	5.06	4.61	3.95	4.12	2.38
Pocfratio	47.51	50.68	35.39	44.43	27.2	46.82
Pfcf Ratio	53.35	54.25	43.51	109.62	39.55	59.43
Days Payables Outstanding	29.45	29.26	54.63	44.0	40.98	54.42
Income Quality	1.06	4.25	1.21	0.78	1.33	1.97
Roe	0.15	0.17	0.0223	0.13	0.22	0.2
Ev To Operating Cash Flow	39.37	45.39	29.84	40.89	25.16	42.75
Pe Ratio	201.91	61.18	27.7	34.8	36.23	34.42
Return On Tangible Assets	0.13	0.15	0.0195	0.11	0.19	0.17
Ev To Free Cash Flow	44.21	48.59	36.69	100.87	36.59	54.27
Earnings Yield	0.0365	0.004953	0.0163	0.0361	0.0287	0.0276
Net Debt To E B I T D A	(81.26)	(5.3)	(3.42)	(2.29)	(2.37)	(2.49)
Current Ratio	12.96	11.18	9.14	4.65	8.84	6.91
Tangible Book Value Per Share	4.98	5.76	5.7	5.47	6.61	6.94
Receivables Turnover	5.28	6.93	8.14	4.02	5.36	6.94
Graham Number	3.59	9.97	11.61	13.19	15.3	16.06
Shareholders Equity Per Share	5.06	5.85	5.86	5.67	6.85	7.19

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether Iradimed is a strong investment it is important to analyze Iradimed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Iradimed's future performance. For an informed investment choice regarding Iradimed Stock, refer to the following important reports:

How To Invest In Iradimed

Details

Is Iradimed Stock a good investment?

Details

What is Iradimed's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.115

Dividend Share

0.47

Earnings Share

1.5

Revenue Per Share

5.781

Quarterly Revenue Growth

0.111

The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Graham Number	Shareholders Equity Per Share
Debt To Equity	Capex Per Share
Graham Net Net	Average Receivables
Revenue Per Share	Interest Debt Per Share
Debt To Assets	Enterprise Value Over E B I T D A
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

Iradimed Historical Financial Ratios

About Iradimed Financial Ratios Analysis

Iradimed Financial Ratios Chart

Price To Sales Ratio

Dividend Yield

Ptb Ratio

Iradimed fundamentals Correlations

Iradimed Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Iradimed fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Pb Ratio	+ 1.0	Ptb Ratio
Ev To Sales	+ 0.99	Price To Sales Ratio
Payout Ratio	+ 0.99	Dividend Yield
Average Inventory	+ 0.97	Book Value Per Share
Capex To Revenue	+ 0.97	Capex To Depreciation
Free Cash Flow Per Share	+ 0.96	Operating Cash Flow Per Share

Days Of Inventory On Hand	- 0.98	Inventory Turnover
Days Payables Outstanding	- 0.96	Payables Turnover
Capex To Revenue	- 0.91	Dividend Yield
Payout Ratio	- 0.87	Capex To Revenue
Capex To Depreciation	- 0.86	Dividend Yield
Average Payables	- 0.85	Dividend Yield